Sunny Side Up | February 9
Sunny Side Up: Your Weekly Dose of Freelance Tips and Local Know-How!
Welcome, Readers to Sunny Side Up! In today’s edition, we’re diving into the world of groundbreaking biotech investments. We’ll explore ARKG, an ETF that focuses on revolutionary technologies like gene editing, CRISPR, and telemedicine, all backed by ARK Invest. With huge potential for transforming healthcare, these innovations could reshape the future—…
Keep reading with a 7-day free trial
Subscribe to 24Hour Journal to keep reading this post and get 7 days of free access to the full post archives.